Main Topic Area
All Topic Areas
1 - 10 of 93 more >>
Articles
1 - 5 of 8 more >>
- FDA Approves Device to Treat Thoracic Insufficiency Syndrome
The Food and Drug Administration (FDA) has approved a Humanitarian Device Exemption (HDE) for an implanted device to treat children who have Thoracic Insufficiency Syndrome, a term used to describe patients who have severe deformities of the chest, spine, and ribs that prevent normal breathing and lung development. An HDE is a special category of approval that allows a manufacturer to market a device on a limited basis to diagnose or treat patients with rare medical conditions—those that...
U.S. Food and Drug Administration
- Pancreatic Islet Transplantation
The pancreas, an organ about the size of a hand, is located behind the lower part of the stomach. It makes insulin and enzymes that help the body digest and use food. Spread all over the pancreas are clusters of cells called the islets of Langerhans. Islets are made up of two types of cells: alpha cells, which make glucagon, a hormone that raises the level of glucose (sugar) in the blood, and beta cells, which make insulin. Islet Functions Insulin is a hormone that helps the body use glucose...
National Institute of Diabetes and Digestive and Kidney Diseases
- Pancreatic Cancer Treatment
Recurrent pancreatic cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the pancreas or in other parts of the body. Treatment of recurrent pancreatic cancer may include the following: Chemotherapy. Palliative surgery or stent placement to bypass blocked areas in ducts or the small intestine. Palliative radiation therapy. Other palliative medical care to reduce symptoms, such as nerve blocks to relieve pain. Clinical trials of chemotherapy or...
National Cancer Institute
- Islet Cell Carcinoma (Pancreatic) Treatment
Treatment may be one of the following: Surgery to remove the cancer. Surgery to remove the stomach (gastrectomy). Surgery to cut the nerve that stimulates the pancreas. Chemotherapy. Hormone therapy. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver. Treatment may be one of the following: Surgery to remove the cancer. Chemotherapy. Hormone therapy. Drugs to relieve symptoms. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver....
National Cancer Institute
- Genes and Disease: Pancreatic cancer
The pancreas is responsible for producing the hormone insulin, along with other substances. It also plays a key role in the digestion of protein. There were an estimated 27,000 new cases of pancreatic cancer in the US in 1997, with 28,100 deaths from the disease. About 90% of human pancreatic carcinomas show a loss of part of chromosome 18. In 1996, a possible tumor suppressor gene, DPC4 (Smad4), was discovered from the section that is lost in pancreatic cancer, so may play a role in pancreatic...
National Center for Biotechnology Information
News
1 - 5 of 223 more >>
- Type 1 diabetes linked to pancreatic cancer risk
Reuters - Thu, 01 Mar 2007 05:24 EST
- Vitamin D Deficiency Widespread During Pregnancy
MedicalNewsToday - Tue, 06 Mar 2007 02:00 EST
- Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- Vitamin D deficiency during pregnancy
The Earth Times - Tue, 27 Feb 2007 08:21 EST
- First Evidence Of Stem Cells In Pancreatic Tumors
ScienceDaily - Mon, 12 Feb 2007 04:00 EST
Clinical Trials
1 - 5 of 621 more >>
- A Open-Label Study to Assess the Safety of Oral Long-Term Use of SA-001 in Pancreatic Exocrine Insufficiency
ClinicalTrials.gov Identifier: NCT00401076 - Recruiting
Pancreatic Exocrine Insufficiency; Chronic Pancreatitis; Pancreatectomy
- A Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
ClinicalTrials.gov Identifier: NCT00297167 - Recruiting
Cystic Fibrosis; Exocrine Pancreatic Insufficiency
- A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
ClinicalTrials.gov Identifier: NCT00400842 - Recruiting
Exocrine Pancreatic Insufficiency; Chronic Pancreatitis
- Efficacy and Safety of ULTRASE MT20 in Improving the Coefficient of Fat Absorption (CFA%) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
ClinicalTrials.gov Identifier: NCT00513682 - Recruiting
Cystic Fibrosis; Pancreatic Insufficiency
- ALTU-135 Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
ClinicalTrials.gov Identifier: NCT00449878 - Recruiting
Cystic Fibrosis; Exocrine Pancreatic Insufficiency

Not Signed In -

